Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44,542,200
-
Total 13F shares
-
10,239,149
-
Share change
-
+349,976
-
Total reported value
-
$164,948,850
-
Price per share
-
$16.11
-
Number of holders
-
43
-
Value change
-
+$6,022,396
-
Number of buys
-
25
-
Number of sells
-
24
Institutional Holders of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) as of Q2 2021
As of 30 Jun 2021 TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) had 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 10,239,149 shares of stock of the company.
Largest 10 holders included ORBIMED ADVISORS LLC, Essex Woodlands Management, Inc., RTW INVESTMENTS, LP, PURA VIDA INVESTMENTS, LLC, Opaleye Management Inc., SILVERCREST ASSET MANAGEMENT GROUP LLC, COWEN AND COMPANY, LLC, VANGUARD GROUP INC, Pentwater Capital Management LP, and ARMISTICE CAPITAL, LLC.
This table shows 43 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.